Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BBIO
#710
BridgeBio Pharma, Inc. - Common Stock
76.6
0
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.64%
Monthly Change
-4.32%
6 month change
+19.02%
Year Change
+34.39%
Previous Close
78.6
8
Open
76.6
0
Low
76.6
0
High
76.6
0
Volume
204
Markets
US Stock Market
Healthcare
Biotechnology
BBIO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
148.96 M
147.61 M
151.37 M
175.83 M
190.19 M
193.86 M
195.49 M
Valuation ratios
Enterprise value
10.38 B
2.5 B
1.15 B
7.19 B
4.99 B
14.27 B
14.97 B
Price to earnings ratio
—
—
-2.2
-10.24
-9.53
-20.24
-22.4
Price to sales ratio
—
—
13.62
707.83
23.01
29.18
21.75
Price to cash flow ratio
—
—
-2.52
-12.48
-9.81
-32.85
-35.68
Price to book ratio
—
—
-0.84
-4.86
-3.48
-7.02
-1.76
Enterprise value to EBITDA ratio
—
-4.38
-2.28
-11.97
-8.49
-27.55
-30.38
Profitability ratios
Return on assets %
-0.72
-0.58
-0.78
-1.2
-0.59
-0.78
-0.13
Return on equity %
-4.76
0.68
0.39
0.49
0.37
0.35
0.06
Return on invested capital %
-1 947.71
-1 696.81
-1 371.23
-2 019.58
-1 289.91
-732.49
-48.47
Gross margin %
100
96.08
100
73.71
98.25
95.82
93.83
Operating margin %
-5 751.99
-827.12
-659.65
-6 528.75
-267.22
-104.25
-43.94
EBITDA margin %
—
-818.73
-650.93
-6 458.95
-264.49
-103.17
-43.51
Net margin %
-6 127.87
-841.2
-624.17
-7 021.94
-244.86
-145.98
-63.97
Liquidity ratios
Quick ratio
—
—
—
—
—
2.68
1.17
Current ratio
6.72
6.58
4.52
3.32
4.67
2.77
1.23
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.08
0.09
0.02
0.3
0.54
0.19
Solvency ratios
Debt to assets ratio
0.13
0.43
0.69
0.82
0.48
—
—
Debt to equity ratio
1.6
-0.49
-0.34
-0.33
-0.3
—
—
Long term debt to total assets ratio
—
0.09
—
—
—
2.14
2.18
Long term debt to total equity ratio
—
-0.11
—
—
—
-0.96
-1.05
Per share metrics
Operating cash flow per share
—
—
-2.84
-3.24
-2.8
-2.33
-2.24
EBIT per share
—
—
-3.47
-3.73
-3.19
-2.73
-2.58
EBITDA per share
—
—
-3.43
-3.69
-3.15
-2.7
-2.55
Total debt per share
—
—
2.92
2.74
2.35
—
—
Cash per share
—
—
3.2
2.67
3.66
3.07
3.68
Net current asset value per share
—
—
3.72
2.93
3.87
4.17
5.58
Tangible book value per share
—
—
-8.51
-8.32
-7.89
-11.04
-12.98
Working capital per share
—
—
2.9
2.05
3.04
2.66
1.03
Book value per share
—
—
-8.51
-8.32
-7.89
-10.89
-12.85
News
BridgeBio Q2 Sales Jump 120% as Attruby Drives Commercial Momentum
Is BBIO a Buy as Fast Sales Growth Meets a Steep Valuation Premium?
Why BBIO Rose 24% in Three Months and Whether the Rally Can Continue
BridgeBio: Attruby Delivers In Q2, Expect Three New Launches In 12 Months (NASDAQ:BBIO)
BridgeBio Q2 Earnings Miss, Revenues Beat as Attruby Sales Surge
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year
BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call Transcript
BridgeBio Pharma (BBIO) Reports Q2 Loss, Tops Revenue Estimates
The Week That Was, The Week Ahead: Macro and Markets, August 9 - TipRanks.com
Viatris Gears Up to Report Q2 Earnings: What's in the Cards?
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?
Tracking Ole Andreas Halvorsen’s Viking Global Portfolio – Q1 2026 Update